Focus on IPAH (PPH) Medical Research

The Cardiovascular Medical Research and Education Fund (CMREF) was created as a non-profit fund operated solely for charitable, scientific and educational purposes. The CMREF mission is the support of research to uncover the etiology and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH, or PPH), in pursuit of the ultimate goal of its treatment and cure.

The immediate objectives are a) to define the cellular basis of IPAH through the study of affected lung tissue, b) to describe the molecular pathways involved in the disease, and c) to identify genetic associations with the IPAH clinical phenotype.

In order to pursue this mission, CMREF is organizing a IPAH Research Network that it will fund through its awards program.